Autologous cell-based therapies for vascular disease

Rajiv Gulati, Robert D. Simari

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Strategies that enhance the number of endothelial cells (ECs) in the vessel wall following injury may limit complications such as thrombosis, vasospasm, and neointimal formation through reconstitution of a luminal barrier and cellular secretion of paracrine factors. Proof of principle has been demonstrated by studies in which mature ECs, culture expanded from harvested vascular tissue, were seeded in the arterial wall following balloon injury. The recent identification of circulating cells capable of developing an endothelial phenotype, including progenitor cells, has raised the possibility of using blood-derived cells as therapeutic agents. This article reviews data suggesting that such cells confer vascular protective effects after injury, raising the potential for novel, autologous approaches to the treatment of vascular disease.

Original languageEnglish (US)
Pages (from-to)262-267
Number of pages6
JournalTrends in Cardiovascular Medicine
Volume14
Issue number7
DOIs
StatePublished - Oct 2004

Fingerprint

Cell- and Tissue-Based Therapy
Vascular Diseases
Blood Vessels
Wounds and Injuries
Endothelial Cells
Blood Cells
Thrombosis
Stem Cells
Cell Culture Techniques
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Autologous cell-based therapies for vascular disease. / Gulati, Rajiv; Simari, Robert D.

In: Trends in Cardiovascular Medicine, Vol. 14, No. 7, 10.2004, p. 262-267.

Research output: Contribution to journalArticle

Gulati, Rajiv ; Simari, Robert D. / Autologous cell-based therapies for vascular disease. In: Trends in Cardiovascular Medicine. 2004 ; Vol. 14, No. 7. pp. 262-267.
@article{a1f2b7f9a6264230b65e3a2dce67c315,
title = "Autologous cell-based therapies for vascular disease",
abstract = "Strategies that enhance the number of endothelial cells (ECs) in the vessel wall following injury may limit complications such as thrombosis, vasospasm, and neointimal formation through reconstitution of a luminal barrier and cellular secretion of paracrine factors. Proof of principle has been demonstrated by studies in which mature ECs, culture expanded from harvested vascular tissue, were seeded in the arterial wall following balloon injury. The recent identification of circulating cells capable of developing an endothelial phenotype, including progenitor cells, has raised the possibility of using blood-derived cells as therapeutic agents. This article reviews data suggesting that such cells confer vascular protective effects after injury, raising the potential for novel, autologous approaches to the treatment of vascular disease.",
author = "Rajiv Gulati and Simari, {Robert D.}",
year = "2004",
month = "10",
doi = "10.1016/j.tcm.2004.07.004",
language = "English (US)",
volume = "14",
pages = "262--267",
journal = "Trends in Cardiovascular Medicine",
issn = "1050-1738",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Autologous cell-based therapies for vascular disease

AU - Gulati, Rajiv

AU - Simari, Robert D.

PY - 2004/10

Y1 - 2004/10

N2 - Strategies that enhance the number of endothelial cells (ECs) in the vessel wall following injury may limit complications such as thrombosis, vasospasm, and neointimal formation through reconstitution of a luminal barrier and cellular secretion of paracrine factors. Proof of principle has been demonstrated by studies in which mature ECs, culture expanded from harvested vascular tissue, were seeded in the arterial wall following balloon injury. The recent identification of circulating cells capable of developing an endothelial phenotype, including progenitor cells, has raised the possibility of using blood-derived cells as therapeutic agents. This article reviews data suggesting that such cells confer vascular protective effects after injury, raising the potential for novel, autologous approaches to the treatment of vascular disease.

AB - Strategies that enhance the number of endothelial cells (ECs) in the vessel wall following injury may limit complications such as thrombosis, vasospasm, and neointimal formation through reconstitution of a luminal barrier and cellular secretion of paracrine factors. Proof of principle has been demonstrated by studies in which mature ECs, culture expanded from harvested vascular tissue, were seeded in the arterial wall following balloon injury. The recent identification of circulating cells capable of developing an endothelial phenotype, including progenitor cells, has raised the possibility of using blood-derived cells as therapeutic agents. This article reviews data suggesting that such cells confer vascular protective effects after injury, raising the potential for novel, autologous approaches to the treatment of vascular disease.

UR - http://www.scopus.com/inward/record.url?scp=8144228275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8144228275&partnerID=8YFLogxK

U2 - 10.1016/j.tcm.2004.07.004

DO - 10.1016/j.tcm.2004.07.004

M3 - Article

VL - 14

SP - 262

EP - 267

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

SN - 1050-1738

IS - 7

ER -